Abstract
Angiotensin may be considered the prototype of the so-called vasoactive peptides inasmuch as its predominant effect is on vascular smooth muscle, which is constricted by both direct and indirect effects of the peptide. However, angiotensin may affect contractility of much extravascular smooth muscle with a predominantly, if not exclusively, stimulatory effect. Here, only the effects on gastrointestinal smooth muscle will be considered.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aboulafia J, Mendes GB, Miyamoto ME, Paiva ACM, Paiva TB (1976) Effect of indomethacin and prostaglandin on the smooth muscle contracting activity of angiotensin and other agonists. Br J Pharmacol 58: 223–228
Bergman J, Oehme P, Jelinek J (1971) Potentiation of angiotensin and eledoisin activities by sodium chloride. Life Sci 17: 969–975
Bertaccini G, Mantovani P, Piccinin GL (1970) Activity ratio between intestinal and cardiovascular actions of caerulein and related substances in the anaesthetized dog. In: Sicuteri F, Rocha e Silva M, Back N (eds) Bradykinin and related kinins. Plenum Press, New York London, pp 213–220
Bertaccini G, Impicciatore M, Molina E, Zappia L (1974) Action of bombesin on human gastrointestinal motility. Rendic, Gastroenterol 6: 45–51
Bisset GW, Lewis GP (1962) A spectrum of pharmacological activity in some biologically active peptides. Brit J Pharmacol 19: 168–182
Blair-West JR, MacKenzie JS (1966) Sodium concentration and the effect of angiotensin II on ileal smooth muscle. Experientia 22: 291
Blumberg A, Denny S, Nishigawa K, Pure E, Marshall GR, Needleman P (1976) Angiotensin III-induced prostaglandin release. Prostaglandins 11: 195–197
Bolton JE, Munday KA, Murley C, Parsons BJ, Poat JA (1976) The relationship between plasma angiotensin II concentrations and fluid transport by rat jejunum in vivo. J Physiol (Lond) 254: 81P-82 P
Braun-Menendez E, Fasciolo JC, Leloir LR, Munoz JM (1940) The substance causing renal hypertension. J Physiol (Lond) 98: 283–298
Bumpus FM, Khosla MC (1977) Angiotensin analogs as determinants of the physiologic role of angiotensin and its metabolites. In: Genest J, Koiw O (eds) Hypertension: physiopathology and treatment. McGraw-Hill, New York, pp 183–201
Castellion AW, Fulton RW (1978) Preclinical pharmacology of saralasin. Kidney Int 15: 511
Cessi C, Bettini V (1973) Sulla presenza di recettori per l’angiotensina nello stomaco di ratto. Boll Soc Ital Biol Sper 24: 433–437
Cessi C, Bettini V (1974) Sull’interazione K angiotensina nello stomaco isolato e denervato di ratto. Boll Soc Ital Biol Sper 50: 1231–1234
Cessi C, Bettini V, Rausse A, Legrenzi E (1977) Interazione angiotensina II-Ca’ sulla „taenia coli“ di cavia. Boll Soc Ital Biol Sper 53: 850–855
Cessi C, Bettini V, Perera E, Legrenzi E (1978) Interazioni acetilcolina-angiotensina sull’at-tività elettrica della „Taenia-coli“. Boll Soc Ital Biol Sper 54: 2444–2449
Chong EKS, Downing OA (1973) Selective inhibition of angiotensin induced contractions of smooth muscle by indomethacin. J Pharm Pharmacol 25: 170–171
Chong EKS, Downing OA (1974) Reversal by prostaglandin E of the inhibitory effect of indomethacin on contractions of guinea-pig ileum induced by angiotensin. J Pharm Pharmacol 26: 729–730
Clineschmidt BV, Geller RG, Govier WC, Pisano JJ, Tanimura T (1971) Effects of ranatensin, a polypeptide from frog skin, on isolated smooth muscle. Br J Pharmacol 41: 622–628
Coruzzi G, Bertaccini G (1980) Action of some vasoactive peptides on the isolated lower esophageal sphincter. Pharmacol Res Commun 12: 965–973
Crocker AD, Wilson KA (1974) A study of the metabolic requirements for the contractile action of angiotensin upon guinea pig ileum. Br J Pharmacol 51: 73–79
Crocker AD, Wilson KA (1975) A further investigation into the energy dependence of angiotensin II-induced contractions of isolated smooth muscle preparations. Br J Pharmacol 53: 59–66
Crocker AD, Mayeka IM, Wilson KA (1979) The role of calcium and cyclic AMP in the contractile action of angiotensin II upon rat descending colon. Eur J Pharmacol 60: 121–129
Deleva JI, Nicolov NA (1977) Effect of angiotensin II on motility and mioelectrical activity of the gastrointestinal tract in dogs. Riv Farmacol Ter 8: 211–218
Deleva JI, Nicolov NA (1979) Effect of angiotensin II on the electric and motor activity of stomach and jejunum after complete vagotomy. Agressologie 20: 161–166
Ercan ZS, Türker RK (1977) A comparison between the prostaglandin releasing effects of angiotensin II and angiotensin III. Agents Actions 7: 569–572
Erspamer V, Melchiorri P, Nakajima T, Yasuhara T, Endean R (1979) Aminoacid composition and sequence of crinia-angiotensin, an angiotensin II-like endecapeptide from the skin of the Australian frog Crinia georgiana. Experientia 35: 1132–1133
Falconieri Erspamer G, Nakajima T, Yasuhara T (1979) Pharmacological data on criniaangiotensin II. J Pharm Pharmacol 31: 720
Famaey JP, Fontaine J, Seaman I, Reuse J (1978) Inhibition of angiotensin-induced contractions of guinea pig isolated ileum by high concentrations of non-steroidal antiinflammatory drugs and various steroids and its reversal by prostaglandin El. Prostaglandins 16: 725–732
Fishlock DJ, Gunn A (1970) The action of angiotensin on the human colon “in vitro.” Br J Pharmacol 39: 34–39
Gagnon DJ, Sirois P (1972) The rat isolated colon as a specific assay organ for angiotensin. Br J Pharmacol 46: 89–93
Gavras H, Gavras I, Brunner HR, Liang CS (1978) Physiologic studies with saralasin in animals. Kidney Int 15: 5–20
Godfraind T, Kaba A, Polster P (1966a) Specific antagonism to the direct and indirect action of angiotensin on isolated guinea-pig ileum. Br J Pharmacol 28: 93–104
Godfraind T, Kaba A, Polster P (1966b) Dissociation in two contractile components on the isolated guinea-pig ileum response to angiotensin. Arch Int Pharmacodyn Ther 163: 227–229
Haulica I, Stanciu CW, Frasin M, Cijevschi C, Balan G, Pancu D (1980) Effects of angiotensin on the human lower esophageal sphincter. Abstr XI Int Congr Gastroenterol. Thieme, Stuttgart, p 28
Huidobro HV, Paladini AC (1963) Potentiation of angiotensin action on smooth muscle by alkaline pH. Experientia 19: 572
Khairallah PA, Page IH (1961) Mechanism of action of angiotensin and bradykinin on smooth muscle in situ. Am J Physiol 200: 51–54
Khairallah PA, Page IH (1963) Effect of bradykinin and angiotensin on smooth muscle. Ann NY Acad Sci 104: 212–220
Khairallah PA, Vandaparampil GJ, Page IH (1965) Effect of ions on angiotensin interaction with smooth muscle. Arch Int Pharmacodyn Ther 158: 155
Khosla MC, Smeby RR, Bumpus FM (1974) Structure-activity relationship in angiotensin II analogs. In: Page IH, Bumpus FM (eds) Angiotensin. Springer, Berlin Heidelberg New York (Handbook of experimental pharmacology, vol 37, pp 126–161 )
Levens NR, Munday KA, York B (1975) Effect of angiotensin II on fluid transport, trans-mural potential difference, and resistance in the rat distal colon in vivo. J Endocrinol 67: 64P-65 P
Lewis GP, Reit E (1965) The action of angiotensin and bradykinin on the superior cervical ganglion of the cat. J Physiol (Lond) 179: 538
Mukhopadhyay AK, Leavitt L (1978) Evidence for an angiotensin receptor in esophageal smooth muscle of the opossum. Am J Physiol 235: E738–E742
Peach MJ (1979) Structural features of angiotensin II which are important for biological activity. Kidney Int 15: 53–56
Pogglitsch H, Holzer H (1971) Die Bestimmung von Angiotensin am isolierten Rattencolon. Wien Klin Wochenschr 83: 894–898
Regoli D, Vane JR (1964) A sensitive method for the assay of angiotensin. Br J Pharmacol 23: 351–359
Regoli D, Park WK, Rioux F (1974a) Pharmacology of angiotensin. Pharmacol Rev 25: 69–123
Regoli D, Rioux F, Park WK, Choi C (1974b) Role of the N-terminal amino acid for the biological activities of angiotensin and inhibitory analogues. Can J Physiol Pharmacol 52: 39–60
Robertson PA, Rubin D (1962) Stimulation of intestinal nervous elements by angiotensin. Br J Pharmacol 19: 5–12
Schwarz H, Bumpus FM, Page IH (1957) Synthesis of a biologically active octapeptide simi-lar to natural isoleucine angiotonin octapeptide. J Am Chem Soc 79: 5697–5703
Schwyzer R, Riniker B, Iselin B, Rittel W, Kapperler H, Zuber H (1958) Val-Hypertensin I and II. Chimia 12: 91
Shehadeh Z, Price WE, Jacobson ED (1969) Effect of vasoactive agents on intestinal blood flow and motility in the dog. Am J Physiol 216: 386–392
Skeggs LT, Marsh WJ, Kahn JR, Shumway NP (1954) The existence of two forms of hypertensin. J Exp Med 99: 275–283
Skeggs LT, Marsh WH, Kahn JR, Shumway NP (1955) Amino acid composition and electrophoretic properties of hypertensin I. J Exp Med 102: 435–440
Skeggs LT, Lentz KE, Shumway NP, Woods KR (1956) The amino acid sequence of hypertensin II. J Exp Med 104: 193–197
Trendelenburg U (1966) Observations on the ganglion-stimulating action of angiotensin and bradykinin. J Pharmacol Exp Ther 154: 418–425
Türker RK (1969) Possible postganglionic adrenergic effect of angiotensin in the isolated perfused cat intestinal segment. Arch Int Physiol Biochim 77: 587–596
Türker RK (1973) Effect of angiotensin on the response to norepinephrine and periarterial stimulation of the isolated perfused cat terminal ileum. Eur J Pharmacol 21: 171–177
Türker RK, Ercan ZS (1978) A comparative study with angiotensin II and ( Des-aspartic acid)’-angiotensin II in the anaesthetized cats. Res Commun Chem Pathol Pharmacol 21: 15–24
Türker RK, Kayaalp SO (1967) Inhibitory effect of angiotensin on intestinal motility of the cat and its relation to sympathetic nervous system. Arch Int Physiol Biochim 75: 735–744
Türker RK, Kaymakcalan S (1971) Effect of morphine and nalorphine on the intestinal mo-tility of the cat. Arch Int Pharmacodyn Ther 193: 397–404
Türker RK, Yamamoto M, Khairallah PA, Bumpus FM (1971) Competitive antagonism of 8-Ala-angiotensin II to angiotensin I and II on isolated rabbit aorta and rat ascending colon. Eur J Pharmacol 15: 285–291
Türker RK, Yamamoto M, Bumpus FM (1973) A new short-acting antagonist of angiotensin II. Arch Int Pharmacodyn Ther 201: 162–169
Vane JR (1974) The fate of angiotensin I. In: Page IH, Bumpus FM (eds) Angiotensin. Springer, Berlin Heidelberg New York (Handbook of experimental pharmacology, vol 37, pp 17–40 )
Zetler G (1979) Antagonism of cholecystokinin-like peptides by opioid peptides, morphine or tetrodotoxin. Eur J Pharmacol 60: 67–77
Aarsen PN (1977) The effects of bradykinin and the bradykinin potentiating peptide BPPSa on the electrical and mechanical responses of the guinea pig taenia coli. Br J Pharmacol 61: 523–532
Aarsen PN, Van Caspel-De Bruyn M (1970) Effect of changes in ionic environment on the action of bradykinin on the guinea-pig taenia coli. Eur J Pharmacol 12: 348–358
Anastasi A, Bertaccini G, Erspamer V (1966a) Pharmacological data on phyllokinin (bra-dykinyl-isoleucyl-tyrosine 0-sulphate) and bradykinyl-isoleucyl-tyrosine. Br J Pharma-col 27: 479–485
Anastasi A, Ersparmer V, Bertaccini G, Cei GM (1966b) Isolation, amino acid sequence, and biological activity of phyllokinin (bradykinyl-isoleucyl-tyrosine 0-sulphate), a bradykinin-like endecapeptide of the skin of Phyllomedusa rohdei. In: Erdös EG, Back N, Sicuteri F (eds) Hypotensive peptides. Springer, Berlin Heidelberg New York, pp 76–84
Antonio A (1968) The relaxing effect of bradykinin on intestinal smooth muscle. Br J Pharmacol 32: 78–86
Barabé J, Park WK, Regoli D (1975) Application of drug receptor theories to the analysis of the myotropic effects of bradykinin. Can J Physiol Pharmacol 53: 345–353
Barabé J, Drouin JN, Regoli D, Park WK (1977) Receptors for bradykinin in intestinal and uterine smooth muscle. Can J Physiol Pharmacol 55: 1270–1285
Bauer G, Gmeiner R, Winkler H (1966a) Über die Wirkung synthetischer Polypeptide auf den Darm in situ. Arch Int Pharmacodyn Ther 159: 373–385
Bauer G, Ziegler E, Konzett H (1966b) Zur Hemmwirkung von Kininen an isolierten Darmpräparaten. Naunyn Schmiedebergs Arch Pharmacol 254: 235–244
Beleslin DB, Bogdanovié SB, Radmanovic BZ (1964) The possible site of action of bradykinin on the peristaltic reflex of the isolated guinea pig ileum. Arch Int Pharmacodyn Ther 147: 43–52
Bertaccini G (1976) Active polypeptides of nonmammalian origin. Pharmacol Rev 28: 127177
Bertaccini G, Cei GM, Erspamer V (1965) Occurrence of physalaemin in extract of the skin in Physalaemus fuscumaculatus and its pharmacological actions on extravascular smooth muscle. Br J Pharmacol 25: 363–379
Bertaccini G, Mantovani P, Piccinin GL (1970) Activity ratio between intestinal and cardiovascular actions of caerulein and related substances in the anaesthetized dog. In: Sicuteri F, Rocha e Silva M, Back N (eds) Bradykinin and related kinins. Plenum, New York London, pp 213–220
Bertaccini G, Impicciatore M, Molina E, Zappia L (1974) Action of bombesin on human gastrointestinal motility. Rend Gastroenterol 6: 45–51
Bertaccini G, Zappia L, Molina E (1979) “In vitro” duodenal muscle in the pharmacological study of natural compounds. Scand J Gastroenterol [Suppl 54] 14:87–93
Bisset GW, Lewis GP (1962) A spectrum of pharmacological activity in some biologically active peptides. Br J Pharmacol 19: 168–182
Bogdanik T, Straczkowski W, Stasiewicz J, Szalaj W (1971) The influence of alfa and betaadrenergic blockade on the duodenal motility; effects of calcium and magnesium ions and bradykinin. In: Union Intern. Thérapeutique (ed) X` Congrès international de thérapeutique. Paris 2–4 Octobre 1969. Doin, Paris, pp 407–415
Bonta IL, Hall DWR (1973) Potentiation of the biphasic bradykinin response of the guinea-pig ileum. Br J Pharmacol 49: 161P-162 P
Camargo A, Ferreira SH (1971) Action of bradykinin potentiating factor (BPF) and dimercaprol ( BAL) on the response to bradykinin of isolated preparations of rat intestines. Br J Pharmacol 42: 305–307
Coruzzi G, Bertaccini G (1980) Action of some vasoactive peptides on the isolated lower esophageal sphincter. Pharmacol Res Commun 12: 965–973
Crocker AD, WalkerR, Wilson KA (1978) Prostaglandins and the contractile action of bra-dykinin on the longitudinal muscle of the rat isolated ileum. Br J Pharmacol 64: 441 P
Crocker AD, Willavoys SP (1976) Possible involvement of prostaglandins in the contractile action of bradykinin on rat terminal ileum. J Pharm Pharmacol 28: 78
Drouin JN, St-Pierre SA, Regoli D (1979a) Receptors for bradykinin and kallidin. Can J Physiol Pharmacol 57: 375–379
Drouin JN, Gaudreau P, St-Pierre S, Regoli D (1979b) Biological activities of kinins modi-fied at the N- or at the C-terminal end. Can J Physiol Pharmacol 57: 1018–1023
Erdös EG (ed) (1970) Handbook of experimental pharmacology, vol XXV: Bradykinin, kal-lidin, and kallikrein. Springer, Berlin Heidelberg New York
Erdös EG (ed) (1979) Handbook of experimental pharmacology, vol XXV Suppl: Bradykinin, kallidin, and kallikrein. Springer, Berlin Heidelberg New York
Erspamer V, Anastasi A (1966) Polypeptides active on plain muscle in the amphibian skin. In: Erdös EG, Back N, Sicuteri F (eds) Hypotensive peptides. Springer, Berlin Heidelberg New York, pp 63–75
Fasth S, Hultén L (1973) The effect of bradykinin on intestinal motility and blood flow. Acta Chir Scand 139: 699–705
Fasth S, Hultén L, Jahnberg T, Martinson J (1975) Comparative studies on the effects of bradykinin and vagal stimulation on motility in the stomach and colon. Acta Physiol Scand 93: 77–84
Fishlock J (1966) Effect of bradykinin on the human isolated small and large intestine. Nature 212: 1533–1535
Gaddum JH, Horton EW (1959) The extraction of human urinary kinin (substance Z) and its relation to the plasma kinins. Br J Pharmacol 14: 117–124
Garcia Leme J, Rocha e Silva M (1965) Competitive and non-competitive inhibition of bradykinin on the guinea pig ileum. Br J Pharmacol 25: 50–58
Gladner JA (1966) Potentiation of the effect of bradykinin. In: Erdös EG, Back N, Sicuteri F (eds) Hypotensive peptides. Springer, Berlin Heidelberg New York, p 344
Gray GW, Yano BL (1975) A study of the actions of methampyrone and of a commercial intestinal extract preparation on intestinal motility. Am J Vet Res 36: 201–208
Hall DWR, Bonta IL (1972) Neurogenic factors involved in the relaxing effect of bradykinin on the isolated guinea-pig ileum. Arch Int Pharmacodyn Ther 197: 380–381
Hall DWR, Bonta IL (1973a) Effects of adrenergic blockers on the relaxation of the guinea pig ileum by bradykinin and adrenaline. Eur J Pharmacol 21: 139–146
Hall DWR, Bonta IL (1973b) The biphasic response of the isolated guinea pig ileum by bradykinin. Eur J Pharmacol 21: 147–154
Hardcastle J, Hardcastle PT, Flower RJ, Sanford PA (1978) The effect of bradykinin on the electrical activity of rat jejunum. Experientia 34: 617–618
Hiatt RB, Goodman I, Bircher R (1966) Control of motility in thiry-vella ileal segments in dogs. Am J Physiol 210: 373–378
Horton EW (1959) Human urinary kinin excretion. Br J Pharmacol 14: 125–132
Iso T, Nishimura K, Oya M, Iwao JI (1979) Potentiating mechanism of bradykinin action on smooth muscle by sulphydryl compounds. Eur J Pharmacol 54: 303–305
Johnson AR (1979) Effects of kinins on organ systems. In: Erdös EG (ed) Bradykinin, kallidin, and kallikrein. Springer, Berlin Heidelberg New York (Handbook of experimental pharmacology, vol XXV Suppl., pp 357–399 )
Konzett H, Stürmer E (1960) Biological activity of synthetic polypeptides with bradykininlike properties. Br J Pharmacol 15: 544–551
Levy B (1963) The intestinal inhibitory response to oxytocin, vasopressin, and bradykinin. J Pharmacol Exp Ther 140: 356–366
Ludâny G, Ihâsz M, Karika J (1967) Bradykinin and motility of the intestinal villi. Med Pharmacol Exp 17: 311–314
Mantovani P, Bertaccini G (1971) Action of caerulein and related substances on gastroin-testinal motility of the anesthetized dog. Arch Int Pharmacodyn Ther 193: 362–371
Mantovani P, Vizi ES (1974) Further observations on the relaxant effect of caerulein on the guinea-pig ileum. J Pharm Pharmacol 26: 461–462
Montgomery EH (1968) The response of the rat duodenum to bradykinin. Proc West Pharmacol Soc 11: 51–52
Murrell TGC, Deller DJ (1967) Intestinal motility in man: the effect of bradykinin on the motility of the distal colon. Dig Dis Sci 12: 568–576
Nakajima T, Yasuhara T, Falconieri Erspamer G, Visser J (1979) Occurrence of Hyp3-bradykinin in methanol extracts of the skin of the South African leptodactylid frog Heleophrine purcelli. Experientia 35: 1133
Oates JA, Melmon K, Sjoerdsma A, Gillespie L, Mason DT (1964) Release of a kinin peptide in the carcinoid syndrome. Lancet 1: 514–517
Odya CE, Goodfriend TL (1979) Bradykinin receptors. In: Erdös EG (ed) Bradykinin, kallidin, and kallikrein. Springer, Berlin Heidelberg New York (Handbook of experimental pharmacology, vol XXV Suppl, pp 287–300 )
Paegelow I, Reissmann S, Vietinghoff G, Römer W, Arold H (1977) Bradykinin action in the rat duodenum through the cyclic AMP system. Agents Actions 7 /4: 447–451
Picarelli ZP (1962) Kininases. Ciencia Cult (Sao Paulo), 14: 232–236
Pisano JJ (1968) Vasoactive peptides in venoms. Fed Proc 27: 58–62
Potter DE, Walaszek EJ (1972) Potentiation of the bradykinin response by cysteine: mechanism of action. Arch Int Pharmacodyn Ther 197: 338–349
Pytkowski B (1979) On the contribution of prostaglandin-like substances to the action of bradykinin on intestinal motility and blood flow in canine jejunal loop in situ. Eur J Clin Invest 9: 391–396
Rocha e Silva M (1972) The kinin trail. Possible significance of bradykinin and related kinins to auto-pharmacology. In: Abstr Fifth Int Congr Pharmacol, San Francisco, p 21
Rocha e Silva M, Rothschild HA (1974) A bradykinin anthology. Sociedade Brasileira de Farmacologia e Terape’utica Experimental, Sao Paulo, pp 1–335
Rocha e Silva M, Beraldo WT, Rosenfeld G (1949) Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin. Am J Physiol 156: 261–273
Sabia EB, Tominaga M, Paiva ACM, Paiva TB (1977) Bradykinin potentiating and sensitizing activities of new synthetic analogues of snake venom peptides. J Med Chem 20: 1679–1681
Schröder E (1970) Structure-activity relationships of kinins In• Erdös EG (ed) Bradykinin, kallidin, and kallikrein. Springer, Berlin Heidelberg New York (Handbook of experimental pharmacology, vol XXV, pp 324–350 )
Shehadeh Z, Price WE, Jacobson ED (1969) Effects of vasoactive agents on intestinal blood flow and motility in the dog. Am J Physiol 216: 386–392
Sherman WT, Gautieri RF (1969) Cardiovascular and gastrointestinal effect of bradykinin and its potentiation by thiols in rats. J Pharm Sci 58: 971–975
Stewart JM (1979) Chemistry and biologic activity of peptides related to bradykinin. In: Erdös EG (ed) Bradykinin, kallidin, and kallikrein. Springer, Berlin Heidelberg New York ( Handbook of experimental pharmacology vol XXV, Suppl, pp 227–272 )
Stürmer E, Berde B (1963) A comparative pharmacological study of synthetic eledoisin and synthetic bradykinin. J Pharmacol Exp Ter 140: 349–355
Tominaga M, Stewart JM, Paiva TB, Paiva ACM (1975) Synthesis and properties of new bradykinin potentiating peptides. J Med Chem 18: 130–133
Türker RK, Ozer A (1970) The effect of prostaglandin E1 and bradykinin on normal and depolarized isolated duodenum of the rat. Agents Actions 1: 124–127
Türker K, Kiran BK, Kaymakcalan S (1964) The effects of synthetic bradykinin on intestinal motility in different laboratory animals and its relation to catecholamines. Arch Int Pharmacodyn Ther 151: 260–268
Ufkes JGR, Van Der Meer C (1975) The effect of catecholamine depletion on the bradyki- nin-induced relaxation of isolated smooth muscle. Eur J Pharmacol 33: 141–144
Ufkes JGR, Aarsen PN, Van Der Meer C (1976) The bradykinin potentiating activity of two pentapeptides on various isolated smooth muscle preparations. Eur J Pharmacol 40: 137–144
Ufkes JGR, Aarsen PN, Van Der Meer C (1977) The mechanism of action of two brady-kinin-potentiating peptides on isolated smooth muscle. Eur J Pharmacol 44: 89–97
Vane JR (1964) The use of isolated organs for detecting active substances in the circulating blood. Br J Pharmacol 23: 360–373
Van Riezen H (1966) Methixene: a non-competitive antagonist of bradykinin. J Pharm Pharmacol 18: 688
Veenendal GH, Van Miert AS, Van Den Ingh TS, Scotman AJ, Zwart D (1976) A comparison of the role of kinins and serotonin in endotoxin induced fever and Trypanosoma vivax infections in the goat. Res Vet Sci 21: 271–279
Veenendaal GH, Woutersen Van Nijnanten FMA, Van Miert ASJPAM (1980) Responses of goat ruminal musculature to bradykinin and serotonin in vitro and in vivo. Am J Vet Res 41: 479–483
Von Klupp H, Konzett H, Winkler H (1964) Zur Wirkung von Bradykinin auf die Darmmotilität in situ. Arch Exp Pathol Pharmakol 247: 325–326
Walker R, Wilson KA (1979) Prostaglandins and the contractile action of bradykinin on the longitudinal muscle of rat isolated ileum. Br J Pharmacol 67: 527–533
Weinberg J, Diniz CR, Mares-Guia M (1976) Influence of sex and sexual hormones in the bradykinin-receptor interaction in the guinea pig ileum. Biochem Pharmacol 25: 433–437
Winkler H, Bauer G, Gmeiner R (1965) Zur Wirkung von Bradykinin, Kallidin und Eledoisin auf den Katzen-und Kaninchen-Darm in situ. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 250: 459–468
Zappia L, Molina E, Violini A, Bassani F (1972) Ricerche preliminari sull’azione del nuovo polipeptide bombesina sull’appendice umana „in vitro“. Ateneo Parmense [Acta Biomed] 43: 3–8
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bertaccini, G. (1982). Peptides: Locally Active Peptides (“Vasoactive Peptides”). In: Bertaccini, G. (eds) Mediators and Drugs in Gastrointestinal Motility II. Handbook of Experimental Pharmacology, vol 59 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68474-6_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-68474-6_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-68476-0
Online ISBN: 978-3-642-68474-6
eBook Packages: Springer Book Archive